Early research (Phase 1)Study completedNCT00561418
What this trial is testing
Vorinostat After Stem Cell Transplant in Treating Patients With High-Risk Lymphoma
Who this might be right for
LymphomaSmall Intestine Cancer
Ohio State University Comprehensive Cancer Center 23